Picture of Shanghai Junshi Biosciences Co logo

1877 Shanghai Junshi Biosciences Co Income Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapSucker Stock

Annual income statement for Shanghai Junshi Biosciences Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSARSARSARSARS
Standards:
CAS
CAS
CAS
CAS
CAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue7751,5954,0251,4531,503
Cost of Revenue
Gross Profit6841,2182,767927868
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses1,5153,2514,5834,1193,960
Operating Profit-740-1,656-558-2,666-2,457
Gain / Loss on Sale of Assets
Other Net Non Operating Costs
Net Income Before Taxes-767-1,672-595-2,677-2,492
Provision for Income Taxes
Net Income After Taxes-748-1,669-731-2,584-2,536
Minority Interest
Net Income Before Extraordinary Items
Net Income-747-1,669-721-2,388-2,283
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-747-1,669-721-2,388-2,283
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.959-2.03-0.811-2.64-2.43
Dividends per Share